MLEC 0.85 Moolec Science SA
| Range: | 0.75-3.25 | Vol Avg: | 23993 | Last Div: | 0 | Changes: | -0.04 |
| Beta: | -0.54 | Cap: | 0.03B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Tue Mar 02 2021 | Empoloyees: | 45 | ||
| CUSIP: | CIK: | 0001937737 | ISIN: | LU2559000059 | Country: | LU | |
| CEO: | Mr. Gaston Paladini M.B.A. | Website: | https://moolecscience.com | ||||
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
Stock Details
MLEC 3
Moolec Science SA (MLEC) PT Lowered to $3 at Maxim Group
Anthony Vendetti·Thu Oct 03 2024
Maxim Group
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow